Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Gateway Health Names Ellen Duffield President and Chief Executive Officer
Gateway Health Plan, Inc. (“Gateway Health”) today appointed Ellen Duffield as President and Chief Executive Officer effective […]
BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors
Today BICO, the world’s leading Bio Convergence company announced it has added Susan Tousi to […]
Novo Nordisk to Acquire Dicerna Pharmaceuticals Including the RNAi Research Technology Platform
Novo Nordisk today announced that it has entered into a definitive agreement to acquire Dicerna […]
Roche Launches Cobas 5800, a New Molecular Diagnostics System to Expand Access to Testing and Improve Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® 5800 System, a new […]
Chroma Medicine Launches with $125M in Financing to Deliver on the Promise of Epigenetic Editing
Chroma Medicine, Inc., (Chroma) a new genomic medicine company pioneering epigenetic editing, launched today with $125M in […]
Rebeca Sanchez Sarmiento Joins Insightful Science and Dotmatics as Chief Financial Officer
Insightful Science, the world’s most widely adopted software platform for scientific R&D and collaboration, today announced […]
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
Terumo Blood and Cell Technologies, a medical technology company specializing in a portfolio of products, […]
FDA Grants AppliedVR Approval for First Virtual Reality Therapeutic to Treat Chronic Low Back Pain
AppliedVR, a pioneer advancing the next generation of immersive therapeutics, today announced that the U.S. […]
Thousands Spared Strokes Thanks to New NHS Drug Agreements
More than 20,000 strokes and 5,000 deaths could be averted after NHS England struck new […]
VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence (AI)
VIDA Diagnostics, Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more